| Product Overview |
| Generic Name | avutometinib / defactinib |
| Brand Name(s) | Avmapki™ Fakzynja™ Co-Pack |
| Form | Co-packaged oral therapy: capsules + tablets |
| Strength | 0.8 mg capsule (avutometinib) + 200 mg tablet (defactinib) |
| Therapeutic Class | Antineoplastic combination; RAF/MEK inhibitor + FAK inhibitor |
| ATC Code | No ATC |
| Manufacturing & Regulatory |
| GMP Compliance | WHO-GMP, EU-GMP |
| COFEPRIS | Under Registration (2025) |
| Logistics & Export |
| MOQ | 10 Units |
| Shelf Life | 24 Months |
| Incoterms | Ex-Works Mexico |
| Lead Time | 7 - 10 Business Days |
| Documentation |
